Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P43026 (
lipopolysaccharide
)
62,215
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
We have examined the tissue distribution of 10-kd inflammatory protein (
IP-10
) mRNA expression in C57Bl/6 mice injected intravenously (i.v.) with various inflammatory stimuli.
IP-10
mRNA was strongly induced by interferon-gamma (IFN-gamma) in liver and kidney but only poorly in skin, heart, and lung. IFN-gamma had nearly equivalent access to these tissues as indicated by the distribution of radiolabeled recombinant IFN-gamma 1 h after injection. The time course of
IP-10
mRNA appearance was rapid and transient in both liver and kidney; maximal expression in the liver (2 h) preceded that in the kidney (3 h) and declined rapidly thereafter in both tissues. Expression of
IP-10
mRNA in the liver and kidney was highly sensitive to IFN-gamma treatment; nearly maximal stimulation occurred with injection of 500 U of IFN-gamma per mouse. Comparable stimulation of
IP-10
mRNA expression in splenic macrophages required 10,000 U of IFN-gamma administered i.v., indicating that liver and kidney responses are 10- to 20-fold more sensitive.
IP-10
mRNA expression in both tissues was not restricted to stimulation by IFN-gamma but was also seen with injection of
lipopolysaccharide
(
LPS
) (25 micrograms/mouse) or IFN-beta (100,000 U/mouse). Two other members of the
IP-10
gene family, KC (gro) and JE (MCP-1), were expressed at lower levels under similar treatment conditions. Analysis of
IP-10
mRNA distribution in the liver and kidney by in situ hybridization indicated that expression in both tissues was most prominent in the reticuloendothelial cell system, particularly in the endothelial lining of the microvascular circulation. Although the function of the
IP-10
gene product has not been defined, these results suggest that it may play an important role in the response of both the liver and kidney to systemic inflammation.
...
PMID:Tissue-specific expression of murine IP-10 mRNA following systemic treatment with interferon gamma. 164 Jan 72
The role of Na+/K+ exchange in regulating
lipopolysaccharide
(
LPS
)-mediated induction of cytokine gene expression has been examined in murine peritoneal macrophages. Depletion of K+ from the culture medium resulted in a three- to five-fold potentiation of tumor necrosis factor-alpha (TNF alpha), KC (gro), and
IP-10
mRNA expression in
LPS
-treated macrophages. The potentiating effect was apparently the result of inhibition of Na+/K+ exchange through the Na+/K(+)-adenosine triphosphatase (ATPase) because ouabain-mediated inhibition of Na+/K(+)-ATPase was also able to potentiate cytokine mRNA expression as much or more than did K+ depletion. The effects of K+ depletion or ouabain treatment were not caused by depolarization of the macrophage membrane because depolarization mediated by elevating extracellular K+ levels was inhibitory to cytokine mRNA expression. Depletion of Na+ by substitution with choline in the culture medium also markedly potentiated
LPS
-induced gene expression. The Na+/H+ antiporter was not, however, involved in potentiating cytokine expression because treatment of macrophages with amiloride either had no effect on or was inhibitory to the
LPS
-induced changes in mRNA levels. The potentiation of gene expression was selective and was at least partially the result of increased transcriptional activity of each gene. Whereas Na+ depletion and ouabain both inhibited 86Rb+ uptake by macrophages, treatment with
LPS
had no effect either on Rb+ uptake or on efflux. Thus altered Na+/K+ exchange is not a component of the primary signalling pathway(s) mediating response to
LPS
. Nevertheless, modulation of macrophage Na+/K+ exchange by agents encountered during an inflammatory response may be an important determinant of the magnitude and quality of specific gene expression.
...
PMID:Modulation of Na+/K+ exchange potentiates lipopolysaccharide-induced gene expression in murine peritoneal macrophages. 165 Mar 75
Our laboratory has recently described the characterization of three distinct cDNAs (designated C7, D3 and D8) encoding genes whose expression is induced in murine peritoneal macrophages by treatment with inflammatory stimuli such as IFNs and
lipopolysaccharide
(
LPS
). Sequence analysis of full-length cDNA for C7 suggests that this encodes the murine homologue of the human IFN gamma-inducible protein
IP-10
. Partial sequence analysis of D3 and D8 cDNAs has revealed no significant homology with known sequences. Treatment of macrophages with the corticosteroid hormone dexamethasone (Dex) suppressed
LPS
-induced gene expression in a selective manner, having little or no effect on induced D3 mRNA levels, but markedly inhibiting the accumulation of both C7 and D8 mRNAs. The suppression of
LPS
-induced C7 and D8 mRNAs was dose-dependent in the range 0.01-10 microM Dex. Furthermore, the inhibitory effect was corticosteroid-specific because testosterone, beta-estradiol and progesterone had no effect on gene expression when used at comparable doses. Inhibition of protein synthesis did not abolish the suppressive activity of Dex, indicating that no intermediate Dex-inducible protein was necessary to suppress the expression of
LPS
-inducible genes. When macrophages were treated with Dex after initiation of
LPS
treatment, the suppressive effects were diminished in a time-dependent fashion. However, even when the hormone was added as much as 2 h after
LPS
, sensitive gene expression was still markedly inhibited. Finally, Dex inhibited the transcription of genes encoding C7 and D8 mRNAs when administered 15 min before
LPS
but had little effect when added 1 h after
LPS
.(ABSTRACT TRUNCATED AT 250 WORDS)
...
PMID:Dexamethasone selectively regulates LPS-inducible gene expression in murine peritoneal macrophages. 169 7
We have examined the effects of interleukin 2 (IL-2) treatment either alone or in combination with interferon (IFN) gamma or beta on the expression of several activation associated genes (e.g. tumor necrosis factor alpha (TNF alpha), IFN-inducible 10-kDa protein (
IP-10
] in murine peritoneal macrophages. IL-2 alone did not induce the expression of either gene while IFN gamma or IFN beta had a modest inductive effect on
IP-10
but no effect on TNF alpha expression. When either form of IFN was used in combination with IL-2 there was a marked synergistic induction of both mRNAs. IFN gamma and IL-2 were maximally effective when both agents were added simultaneously, and induced mRNA expression declined over a 24-h period in cells pretreated with IFN gamma prior to addition of IL-2. Expression of both genes following combination lymphokine treatment was mediated by increased transcriptional activity. The responses to all three lymphokines were dose dependent; the concentration requirement for IL-2 indicated interaction with an intermediate or low affinity receptor. The expression of both monokine genes was transient and was comparable although not identical to that seen in cells stimulated with
lipopolysaccharide
. IFN gamma and IL-2 could synergize to stimulate the expression of either TNF alpha or
IP-10
mRNA using sequential non-overlapping treatment periods regardless of the order in which the two stimuli were applied to the cells. The effect of either agent alone induced a transient (1-5 h) responsive state with respect to subsequent stimulation with the second agent. Expression of both monokine genes in response to IFN gamma/IL-2 treatment was independent of protein synthesis as cycloheximide did not inhibit the accumulation of specific mRNA. Interestingly, the combination of IL-2 and cycloheximide was as effective as IFN gamma and IL-2 together. In concert, these results indicate that both IFN and IL-2 generate independent intracellular signals which alone are incapable of inductive effect but which are potent activators of inflammatory gene expression when coincidentally expressed.
...
PMID:Interferon gamma and interleukin 2 synergize to induce selective monokine expression in murine peritoneal macrophages. 210 65
In order to identify novel proteins produced by activated macrophages, a cDNA library was made from cultures of the mouse macrophage-like cell line RAW 264.7 that had been treated with conditioned medium from mitogen-stimulated spleen cells, and the library was screened by differential plaque hybridization. A cDNA clone was isolated that detected a 1.4-kilobase mRNA that accumulated dramatically in response to the spleen cell conditioned medium. The 1.4-kilobase mRNA encodes a predicted protein of 98 amino acids, designated CRG-2, molecular weight (Mr) 10,781, with a 21-residue signal peptide. The amino acid sequence indicates that CRG-2 is a member of the platelet factor 4 family (PF4) of cytokines. The CRG-2 mRNA was induced by alpha-, beta-, and gamma-interferons (IFNs) and by
lipopolysaccharide
. In response to IFN-gamma, the CRG-2 mRNA level reached a peak between 3 and 6 h. The accumulation of CRG-2 mRNA was not blocked by cycloheximide. Among the known members of the PF4 family, CRG-2 is most closely related to the interferon-inducible human protein
IP-10
. The 5'-flanking region of the
crg-2
gene was isolated, and comparisons between
crg-2
and
IP-10
genes, mRNAs, and proteins reveal conserved features of possible functional importance. CRG-2 may play a role in host defense, particularly in the response to viral infection.
...
PMID:Identification of CRG-2. An interferon-inducible mRNA predicted to encode a murine monokine. 211 20
Recently, we have isolated and characterized a set of cDNA clones which encode
lipopolysaccharide
-inducible proteins in murine peritoneal macrophages. Here, we report the sequence and identification of one of these cDNAs previously termed C7. Nucleotide sequence analysis revealed an open reading frame encoding a predicted polypeptide composed of 98 amino acids, which contained a 21 amino acid residue signal peptide, indicating approximately 9 kDa of mature protein. The deduced protein sequence showed homology (67% identity, 77% considering conservative amino acid changes) with the human INF gamma-inducible gene
IP-10
, a member of the recently described superfamily of chemotactic and mitogenic proteins which includes platelet factor 4, monocyte-derived neutrophil chemotactic factor (NAF, NAP-1, IL-8), and MGSA/gro/KC. Thus C7 would appear to represent the murine homologue of the human
IP-10
gene or a very closely related gene.
...
PMID:A macrophage LPS-inducible early gene encodes the murine homologue of IP-10. 218 6
Macrophages are stimulated by
lipopolysaccharide
(
LPS
) of gram-negative organisms. The changes in
LPS
-stimulated macrophages include transcriptional activation of multiple immediate-early genes, which may contribute to the natural immunity to microorganisms. We have defined by deletion and mutational analysis
LPS
-responsive elements (LREs) in two chemokine genes, MuRantes and
crg-2
, which are activated in an immediate-early manner. LRE consists of two motifs, TCAYR, which is an AP-1 half site with two flanking bases, and (A/T) (G/C)NTTYC(A/T)NTTY, which resembles in part the interferon-stimulated responsive element (ISRE). The orientation of these two motifs relative to each other in MuRantes differed from that in
crg-2
. These two motifs are separated by 10 and 6 nonconsensus nucleotides in the MuRantes and
crg-2
LREs, respectively. Stimulation of macrophage-like RAW 264.7 cells with alpha/beta interferon did not activate MuRantes, indicating that the ISRE-like motif in MuRantes does not have ISRE activity. Upon stimulation of RAW 264.7 cells with
LPS
, proteins capable of binding to LRE accumulate in the nuclei as measured by electrophoretic mobility shift assay. These LRE-binding proteins include c-Jun and CREB.
...
PMID:Definition of a lipopolysaccharide-responsive element in the 5'-flanking regions of MuRantes and crg-2. 751 46
A major part of the anti-inflammatory effect of glucocorticoids is attributable to their attenuation of the induction of genes whose products mediate intercellular interactions, e.g. cytokines and the inducible forms of prostaglandin synthase and nitric oxide synthase. We hypothesized that (i) there exists a class of immediate-early/primary response genes whose induction by inflammatory agents, mitogens, and other stimuli is attenuated by glucocorticoids, and (ii) the products of these glucocorticoid-attenuated response genes (GARGs) function predominantly in paracrine cell processes. We constructed a lambda cDNA library from transforming growth factor beta 1-pretreated murine Swiss 3T3 cells stimulated with
lipopolysaccharide
(
LPS
) or serum in the presence of cycloheximide, screened 15,000 plaques by differential hybridization, and cloned 12
LPS
-induced, dexamethasone-attenuated cDNAs. Seven were previously known. Six of these encode intercellular mediators (thrombospondin-1, MCSF, JE/MCP-1, MARC/fic/MCP-3, crg2/
IP-10
, and cyr61); one encodes a protein of unknown function (IRG2). Thus, a large majority of these GARG cDNAs encode intercellular mediators, as hypothesized. Of the five GARG cDNAs not previously known, one encodes a novel member of the CXC chemokine family, designated LIX (
LPS
-induced CXC chemokine). The predicted LIX protein has a 40-amino acid signal sequence and a 92-amino acid mature peptide with a distinctive COOH-terminal region. Surprisingly, segments of the 3'-untranslated regions of LIX and two other CXC chemokines have substantially greater nucleotide sequence homology than do their coding regions. These segments may perform an unknown regulatory function. The LIX message is strongly induced by
LPS
in fibroblasts, but not in macrophages, suggesting that LIX may participate in the recruitment of inflammatory cells by injured or infected tissue.
...
PMID:Glucocorticoid-attenuated response genes encode intercellular mediators, including a new C-X-C chemokine. 762 88
Numerous lipid A analogs have been synthesized in an attempt to dissociate endotoxic activities from beneficial immunomodulatory activities. In the present study, we have evaluated select lipid A analogs in macrophages for their ability to induce a panel of
lipopolysaccharide
(
LPS
)-inducible genes to gain insights into the molecular mechanisms which underlie endotoxicity. We evaluated three monosaccharide lipid A analogs: SDZ MRL 953, an agonist with an improved therapeutic margin over endotoxin; SDZ 281.288, a more toxic analog; and SDZ 880.431, an analog with proven
LPS
-inhibitory activity. In addition, three disaccharide lipid A analogs (i.e., lipid IVA, SDZ 880.611, and SDZ 880.924) that differ in acylation and phosphorylation patterns were also examined and compared with synthetic lipid A. With the exception of SDZ 880.431, each of these structurally diverse analogs was able to induce the complete panel of
LPS
-inducible genes, specifically genes which encode tumor necrosis factor alpha (TNF-alpha), interleukin-1 beta, 75-kDa type 2 TNF receptor (D7),
IP-10
, D3, and D8. These results underscore that macrophage stimulation by lipid A analogs is permissive to considerable structural diversity. Structures with favorable therapeutic indices (SDZ MRL 953, SDZ 880.611, and SDZ 880.924) were not different from structures with poor therapeutic indices (lipid A, lipid IVA, and SDZ 281.288) with regard to gene induction. Nonetheless, the nontoxic SDZ MRL 953 was approximately 1,000-fold less potent than synthetic lipid A at inducing TNF-alpha secretion, and perhaps this contributes to the lack of toxicity exhibited by this compound. The ability of compound SDZ 880.431 to inhibit TNF-alpha secretion induced by both SDZ MRL 953 and smooth
LPS
suggests that the monosaccharide and smooth
LPS
share a receptor or a portion thereof. A pattern of protein tyrosine phosphorylation similar to that induced by
LPS
was stimulated by the monosaccharide SDZ MRL 953 and SDZ 281.288 and disaccharides lipid IVA, SDZ 880.924, and SDZ 880.611, providing evidence for a common signalling pathway.
...
PMID:Induction of early gene expression in murine macrophages by synthetic lipid A analogs with differing endotoxic potentials. 768 1
IP-10
is a member of the chemokine family of cytokines and is induced in a variety of cells in response to interferon gamma and
lipopolysaccharide
. The self-aggregation common to many chemokines, including
IP-10
, has hindered the identification of a specific IP-10 receptor. Using an
IP-10
alkaline phosphatase fusion protein that fortuitously blocks this self-aggregation, we have identified an
IP-10
binding site on a variety of cells including endothelial, epithelial, and hematopoietic cells. This binding site has a Kd of 25 nM, is inhibited by recombinant murine or human
IP-10
, and is dependent on the presence of cell surface heparan sulfate proteoglycans (HSPG). This conclusion is based on the findings that
IP-10
binding to cells is: (a) inhibited by heparin and heparan sulfate; (b) sensitive to a 1 M NaCl wash; (c) eliminated by treatment with heparinase and trypsin; and (d) absent on mutant CHO cells that do not express cell surface HSPG. Platelet factor 4 (PF4), but not IL-8, monocyte chemoattractant protein-1, RANTES, monocyte inflammatory protein (MIP)-1 alpha, or MIP-1 beta, can compete effectively with
IP-10
for binding to the cell surface. Furthermore,
IP-10
shares with PF4 the ability to inhibit endothelial cell proliferation (IC50 = 150 nM). These studies demonstrate specificity in the interaction of chemokines and HSPG, and they define
IP-10
and PF4 as a distinct subset of chemokines sharing an HSPG-binding site and angiostatic properties.
...
PMID:The IP-10 chemokine binds to a specific cell surface heparan sulfate site shared with platelet factor 4 and inhibits endothelial cell proliferation. 779 Aug 18
1
2
3
4
5
6
7
8
9
10
Next >>